Proxy adviser ISS recommends rejecting CoreWeave's $9 billion bid to acquire Core Scientific, citing concerns over the "rushed sale process" and "fixed exchange ratio" that undervalue Core Scientific.
Motorola beats Q3 estimates, raises 2025 EPS guidance, and cites robust demand for public-safety and government solutions as key growth drivers.
Proxy adviser ISS recommends rejecting CoreWeave's $9 billion bid to acquire Core Scientific, citing concerns over the "rushed sale process" and "fixed exchange ratio" that undervalue Core Scientific.
Motorola beats Q3 estimates, raises 2025 EPS guidance, and cites robust demand for public-safety and government solutions as key growth drivers.